Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Vaccination and passive immunisation against Staphylococcus aureus.

Schaffer AC, Lee JC.

Int J Antimicrob Agents. 2008 Nov;32 Suppl 1:S71-8. doi: 10.1016/j.ijantimicag.2008.06.009. Epub 2008 Aug 30. Review.

PMID:
18757184
2.

Staphylococcal vaccines and immunotherapies.

Schaffer AC, Lee JC.

Infect Dis Clin North Am. 2009 Mar;23(1):153-71. doi: 10.1016/j.idc.2008.10.005. Review.

PMID:
19135920
3.

Staphylococcus aureus vaccine conjugate--Nabi: Nabi-StaphVAX, StaphVAX.

[No authors listed]

Drugs R D. 2003;4(6):383-5. Review.

PMID:
14584973
5.

Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.

Fattom AI, Horwith G, Fuller S, Propst M, Naso R.

Vaccine. 2004 Feb 17;22(7):880-7. Review.

PMID:
15040941
6.

Staphylococcus aureus antigens and challenges in vaccine development.

Middleton JR.

Expert Rev Vaccines. 2008 Aug;7(6):805-15. doi: 10.1586/14760584.7.6.805. Review.

PMID:
18665778
7.

Prevention of Staphylococcus aureus infections: advances in vaccine development.

Shinefield HR, Black S.

Expert Rev Vaccines. 2005 Oct;4(5):669-76. Review.

PMID:
16221068
8.

Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.

Li X, Wang X, Thompson CD, Park S, Park WB, Lee JC.

MBio. 2016 Feb 2;7(1):e02232-15. doi: 10.1128/mBio.02232-15.

9.

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.

Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS.

Infect Immun. 2006 Apr;74(4):2215-23.

10.

Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.

McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB.

Science. 1999 May 28;284(5419):1523-7.

11.

Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.

Creech CB 2nd, Johnson BG, Alsentzer AR, Hohenboken M, Edwards KM, Talbot TR 3rd.

Vaccine. 2009 Dec 10;28(1):256-60. doi: 10.1016/j.vaccine.2009.09.088. Epub 2009 Sep 30.

PMID:
19799842
12.

The prospects for developing a vaccine against Staphylococcus aureus.

Lee JC.

Trends Microbiol. 1996 Apr;4(4):162-6. Review.

PMID:
8728611
13.

Immunotherapeutic strategies to combat staphylococcal infections.

Ohlsen K, Lorenz U.

Int J Med Microbiol. 2010 Aug;300(6):402-10. doi: 10.1016/j.ijmm.2010.04.015. Epub 2010 May 23. Review.

PMID:
20547101
14.

Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.

Schaffer AC, Solinga RM, Cocchiaro J, Portoles M, Kiser KB, Risley A, Randall SM, Valtulina V, Speziale P, Walsh E, Foster T, Lee JC.

Infect Immun. 2006 Apr;74(4):2145-53.

15.

Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo.

Vernachio JH, Bayer AS, Ames B, Bryant D, Prater BD, Syribeys PJ, Gorovits EL, Patti JM.

Antimicrob Agents Chemother. 2006 Feb;50(2):511-8.

16.

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.

Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, Naso R, Horwith G.

Vaccine. 2004 Dec 16;23(5):656-63.

PMID:
15542186
17.
18.

Immunotherapeutic approaches against Staphylococcus aureus.

Verkaik NJ, van Wamel WJ, van Belkum A.

Immunotherapy. 2011 Sep;3(9):1063-73. doi: 10.2217/imt.11.84. Review.

PMID:
21913829
19.

Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.

Broughan J, Anderson R, Anderson AS.

Expert Rev Vaccines. 2011 May;10(5):695-708. doi: 10.1586/erv.11.54. Review.

PMID:
21604989
20.

DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.

Nour El-Din AN, Shkreta L, Talbot BG, Diarra MS, Lacasse P.

Vaccine. 2006 Mar 15;24(12):1997-2006. Epub 2005 Dec 1.

PMID:
16426711

Supplemental Content

Support Center